In Europe and the US, prostate cancer incidence rates have also increased and are most likely due to an increased awareness of prostate-related symptoms, improved access to health care, and increased diagnostic activity through prostate-specific antigen (PSA) testing [7]. The gene discussed is KLK3; the disease is Familial prostate cancer.